{"owner": "ArrayExpress Uploader", "pop_total": 0, "id": 4915, "factors": [{"GSE7538GSM182629": {"stimulus": "parthenolide"}}, {"GSE7538GSM182629": {"stimulus": "parthenolide"}}, {"GSE7538GSM182629": {"stimulus": "parthenolide"}}, {"GSE7538GSM182629": {"stimulus": "parthenolide"}}, {"GSE7538GSM182629": {"stimulus": "parthenolide"}}, {"GSE7538GSM182629": {"stimulus": "parthenolide"}}, {"GSE7538GSM182629": {"stimulus": "parthenolide"}}, {"GSE7538GSM182629": {"stimulus": "parthenolide"}}, {"GSE7538GSM182629": {"stimulus": "parthenolide"}}, {"GSE7538GSM182629": {"stimulus": "parthenolide"}}, {"GSE7538GSM182629": {"stimulus": "parthenolide"}}, {"GSE7538GSM182629": {"stimulus": "parthenolide"}}, {"GSE7538GSM182630": {"stimulus": "control"}}, {"GSE7538GSM182630": {"stimulus": "control"}}, {"GSE7538GSM182630": {"stimulus": "control"}}, {"GSE7538GSM182630": {"stimulus": "control"}}, {"GSE7538GSM182630": {"stimulus": "control"}}, {"GSE7538GSM182630": {"stimulus": "control"}}, {"GSE7538GSM182630": {"stimulus": "control"}}, {"GSE7538GSM182630": {"stimulus": "control"}}, {"GSE7538GSM182630": {"stimulus": "control"}}, {"GSE7538GSM182630": {"stimulus": "control"}}, {"GSE7538GSM182630": {"stimulus": "control"}}, {"GSE7538GSM182630": {"stimulus": "control"}}], "ownerprofile_id": "arrayexpress_sid", "platform": 4, "summary_wrapped": "The effects of 7.5 micromolar parthenolide (PTL) were assessed on primary CD34+ acute myelogenous leukemia specimens obtained from 12...", "pubmed_id": 18305216, "geo_gse_id": "E-GEOD-7538", "owner_profile": "/profile/8773/arrayexpressuploader", "factor_count": 1, "sample_count": 24, "tags": ["left", "leukemia"], "lastmodified": "Dec.12, 2014", "is_default": false, "geo_gds_id": "", "slug": "transcription-profiling-of-human-primary-cd34-acut", "geo_id_plat": "E-GEOD-7538_A-AFFY-44", "name": "Transcription profiling of human primary CD34+ acute myelogenous leukemia specimens obtained from 12 patients treated with 7.5 micromolar parthenolide (PTL)", "created": "Sep.22, 2014", "summary": "The effects of 7.5 micromolar parthenolide (PTL) were assessed on primary CD34+ acute myelogenous leukemia specimens obtained from 12 patients. Experiment Overall Design: Acute myelogenous leukemia (AML) specimens were obtained from 12 patients and CD34+ cells were isolated.  For each patient, cells were cultured in vitro and exposed to either 7.5 micromolar parthenolide (PTL) or left untreated (UT) for 6 h.  Total RNA was then harvested for global gene expression analysis.", "source": "http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-7538", "species": "human", "sample_source": "http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-7538/samples/"}